Literature DB >> 21656904

Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations.

Rungnapa Ittiwut1, Jennifer B Listman, Chupong Ittiwut, Joseph F Cubells, Roger D Weiss, Kathleen Brady, David Oslin, Lindsay A Farrer, Henry R Kranzler, Joel Gelernter.   

Abstract

Catechol-O-methyltransferase (genetic locus, COMT) is a major enzyme involved in catecholamine metabolism and has been associated with numerous psychiatric phenotypes. We studied COMT SNPs and haplotypes in cocaine-induced paranoia (CIP) in African-American (AA) and European-American (EA) populations. We genotyped 17 SNPs across the COMT locus in 319 AA pedigrees (848 individuals) and 302 EA pedigrees (707 individuals). Family-controlled association analyses were conducted using FBAT. We found SNP rs737865 to be nominally significantly associated in the AA family population (P = 0.05). In EAs, the best-known marker, rs4680 (Val158Met), was nominally significant in additive models (P = 0.03). SNP rs174696 also showed nominal significance in additive models (P = 0.02). We considered the three SNPs (rs737866-rs4680-rs174696) together in haplotype analysis in both family populations, using HBAT. The A-A-T haplotype was significantly associated with CIP in EAs (Z = 2.845; P = 0.0044, global P = 0.020). We then studied COMT SNPs in an additional 738 AA and 404 EA unrelated cocaine dependent individuals with and without paranoia. The A-A-T haplotype was significantly associated to CIP in the AA unrelated population (P = 0.0015). Two haplotypes, A-G-C and A-A-C, were significant in the EA unrelated population (P = 0.001 and 0.0003). We also identified rs4680 and three other SNPs, rs933271, rs5993883, and rs740603, as potentially functional variants, as predicted by a signature of positive selection in unrelated EAs and AAs. Based on our robust family-controlled and unrelated-affected analyses, we conclude that COMT is associated with CIP, possibly as a result of its role in the metabolism of dopamine and norepinephrine.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21656904      PMCID: PMC3864552          DOI: 10.1002/ajmg.b.31205

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  38 in total

1.  Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations.

Authors:  Joke Beuten; Thomas J Payne; Jennie Z Ma; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

2.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

3.  The family based association test method: strategies for studying general genotype--phenotype associations.

Authors:  S Horvath; X Xu; N M Laird
Journal:  Eur J Hum Genet       Date:  2001-04       Impact factor: 4.246

4.  Impact of complex genetic variation in COMT on human brain function.

Authors:  A Meyer-Lindenberg; T Nichols; J H Callicott; J Ding; B Kolachana; J Buckholtz; V S Mattay; M Egan; D R Weinberger
Journal:  Mol Psychiatry       Date:  2006-06-20       Impact factor: 15.992

5.  Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia.

Authors:  Joel Gelernter; Carolien Panhuysen; Roger Weiss; Kathleen Brady; Victor Hesselbrock; Bruce Rounsaville; James Poling; Marsha Wilcox; Lindsay Farrer; Henry R Kranzler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-07-05       Impact factor: 3.568

6.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

7.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

8.  COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.

Authors:  Doron Gothelf; Stephan Eliez; Tracy Thompson; Christine Hinard; Lauren Penniman; Carl Feinstein; Hower Kwon; Shuting Jin; Booil Jo; Stylianos E Antonarakis; Michael A Morris; Allan L Reiss
Journal:  Nat Neurosci       Date:  2005-10-23       Impact factor: 24.884

9.  Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles A Dackis; Charles P O'Brien; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

10.  Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia.

Authors:  J Gelernter; H R Kranzler; S L Satel; P A Rao
Journal:  Neuropsychopharmacology       Date:  1994-11       Impact factor: 7.853

View more
  16 in total

1.  COMT Val158Met polymorphism is associated with blood pressure and lipid levels in general families of Bama longevous area in China.

Authors:  Lin Ge; Hua-Yu Wu; Shang-Ling Pan; Ling Huang; Peng Sun; Qing-Hua Liang; Guo-Fang Pang; Ze-Ping Lv; Cai-You Hu; Cheng-Wu Liu; Xiao-Ling Zhou; Ling-Jin Huang; Rui-Xing Yin; Jun-Hua Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.

Authors:  Orna Levran; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Ann Hum Genet       Date:  2015-02-27       Impact factor: 1.670

Review 3.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

4.  Association of maternal and infant variants in PNOC and COMT genes with neonatal abstinence syndrome severity.

Authors:  Elisha M Wachman; Marie J Hayes; Richard Sherva; Mark S Brown; Hira Shrestha; Beth A Logan; Nicole A Heller; David A Nielsen; Lindsay A Farrer
Journal:  Am J Addict       Date:  2016-12-16

Review 5.  The genetic epidemiology of substance use disorder: A review.

Authors:  Elizabeth C Prom-Wormley; Jane Ebejer; Danielle M Dick; M Scott Bowers
Journal:  Drug Alcohol Depend       Date:  2017-08-01       Impact factor: 4.492

Review 6.  Environmental, genetic and epigenetic contributions to cocaine addiction.

Authors:  R Christopher Pierce; Bruno Fant; Sarah E Swinford-Jackson; Elizabeth A Heller; Wade H Berrettini; Mathieu E Wimmer
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

7.  Association of catechol-O-methyltransferase gene polymorphisms with schizophrenia and negative symptoms in a Chinese population.

Authors:  Wen Jun Li; Chang Gui Kou; Yaqin Yu; Shilong Sun; Xuan Zhang; Thomas R Kosten; Xiang Yang Zhang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-02-21       Impact factor: 3.568

8.  Dopamine gene variants in opioid addiction: comparison of dependent patients, nondependent users and healthy controls.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Vadim Yuferov; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2017-12-06       Impact factor: 2.533

9.  Variations in opioid receptor genes in neonatal abstinence syndrome.

Authors:  Elisha M Wachman; Marie J Hayes; Richard Sherva; Mark S Brown; Jonathan M Davis; Lindsay A Farrer; David A Nielsen
Journal:  Drug Alcohol Depend       Date:  2015-07-08       Impact factor: 4.492

Review 10.  The genetics of addiction-a translational perspective.

Authors:  A Agrawal; K J H Verweij; N A Gillespie; A C Heath; C N Lessov-Schlaggar; N G Martin; E C Nelson; W S Slutske; J B Whitfield; M T Lynskey
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.